REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,601 | +323.3% | 1,248,586 | +438.7% | 0.11% | +303.7% |
| Q1 2023 | $7,465 | -99.5% | 231,776 | +144.7% | 0.03% | +440.0% |
| Q1 2016 | $1,653,000 | -92.1% | 94,700 | -84.5% | 0.01% | -92.1% |
| Q4 2015 | $20,830,000 | +250.8% | 609,768 | +205.6% | 0.06% | +250.0% |
| Q3 2015 | $5,938,000 | -7.8% | 199,544 | -0.9% | 0.02% | +5.9% |
| Q2 2015 | $6,439,000 | +19.6% | 201,366 | -27.7% | 0.02% | +21.4% |
| Q3 2014 | $5,385,000 | -60.5% | 278,607 | -30.6% | 0.01% | -12.5% |
| Q2 2014 | $13,646,000 | +249.6% | 401,366 | +223.9% | 0.02% | +77.8% |
| Q1 2014 | $3,903,000 | – | 123,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
| Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
| Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
| Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
| ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
| Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
| Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
| C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
| NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
| WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |